Medium materiality6/10
H.C. Wainwright upgrades Inovio Pharmaceuticals (INO) to Buy
Why it may matterVerify against the original reporting
Bullish analyst call, with substantial implied upside but elevated uncertainty.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright upgraded INO to Buy and set a $5 target versus the posted price of $1.74. The implied upside is large, but this is a single analyst view on a low-priced biotech stock.
- H.C. Wainwright rating: Buy
- Target: $5; posted price: $1.74
Key facts
- 01
Target: $5
- 02
Posted price: $1.74
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Yi Chen
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.